CompletedNot Applicable

Effect of QR Code-Supported Infant Care Education on Maternal Self-Confidence, Maternal Attachment, and Infant Health in the NICU

Turkey (Türkiye)84 participantsStarted 2025-06-02

Plain-language summary

This randomized controlled trial aims to evaluate the effect of Meleis' Transitions Theory-based Quick Response (QR) code-supported infant care education on maternal self-confidence, maternal attachment, and infant health among primiparous mothers whose infants are hospitalized in the neonatal intensive care unit (NICU). Participants were randomly assigned to either an intervention group or a control group using block randomization. Mothers in the intervention group received face-to-face infant care education before discharge, a printed infant care guide containing QR codes linked to educational videos, and instructions on how to use a mobile application. Mothers in the control group received routine care and discharge education provided by the NICU. Maternal self-confidence, maternal attachment, and infant health outcomes were assessed before discharge and at one and three months after discharge. This study is expected to provide evidence regarding the effectiveness of QR code-supported infant care education in improving maternal adaptation and infant health outcomes following NICU discharge.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primiparous mothers with a singleton birth, * Aged 18 years or older, * Able to read and communicate in Turkish, * Owning a smartphone with internet access and having sufficient digital literacy to use QR code applications, * No diagnosed psychiatric disorder, * Mothers whose infants had been hospitalized in the neonatal intensive care unit for at least one month, * Willing to participate and providing written informed consent, * Infants with a gestational age of ≥34 weeks, * Infants without life-threatening congenital, neurological, gastrointestinal, or genetic disorders requiring surgical intervention or expected to affect long-term prognosis. Exclusion Criteria: * Mothers who did not continue in the post-discharge follow-up period, * Participants whose mother or infant died (exitus) during the study period.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Maternal Self-Confidence

Timeframe: Baseline (approximately 1 week before discharge and prior to the intervention), 1 month after discharge, and 3 months after discharge

Maternal Attachment

Timeframe: Baseline (approximately 1 week before discharge and prior to the intervention), 1 month after discharge, and 3 months after discharge

Infant Health

Timeframe: Baseline (approximately 1 week before discharge and prior to the intervention), 1 month after discharge, and 3 months after discharge

Trial details

NCT IDNCT07763041

SponsorAnkara Medipol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-26

View on ClinicalTrials.gov More QR Code-Supported Infant Care Education trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Maternal Self-Confidence

Timeframe: Baseline (approximately 1 week before discharge and prior to the intervention), 1 month after discharge, and 3 months after discharge

Maternal Attachment

Timeframe: Baseline (approximately 1 week before discharge and prior to the intervention), 1 month after discharge, and 3 months after discharge

Infant Health

Timeframe: Baseline (approximately 1 week before discharge and prior to the intervention), 1 month after discharge, and 3 months after discharge